SCHEMBL29060280

SCHEMBL29060280

COC(=O)c1nc(Cl)c(C(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ PIM3 Q86V86 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ VCAM1 P19320 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ FLT1 P17948 1/20 0.35
▸ FGFR3 P22607 1/20 0.35
▸ KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24241501 0.85 PIM3 (0.38) MAPTPOLBMAPK1PIM3ALDH1A1
SCHEMBL30398167 0.85 PIM3 (0.38) MAPTPOLBMAPK1PIM3ALDH1A1
SCHEMBL29662618 0.79 MAPT (0.41) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL29060204 0.79 MAPT (0.41) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL29381761 0.78 AR (0.42) MAPTPOLBMAPK1KMT2AALDH1A1
SCHEMBL24241065 0.78 AR (0.42) MAPTPOLBMAPK1KMT2AALDH1A1
SCHEMBL24241258 0.74 POLB (0.33) MAPTPOLBMAPK1KMT2APIM3
SCHEMBL23363887 0.73 MEN1 (0.42) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL20476371 0.72 PDGFRB (0.45) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL2342890 0.70 MAPT (0.41) MAPTPOLBMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4247817-A1 MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-09-27 — — EP disclosed
CN-116670140-A Macrocyclic compounds containing 1,3, 4-oxadiazole rings as modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-08-29 — — CN disclosed
WO-2022109573-A1 MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-05-27 — — WO disclosed
Send feedback